Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients
BMC Nephrology, 10/27/09
Reed A et al. – This study will determine the time and dose required for alpha tocopherol to significantly decrease oxidative stress in haemodialysis patients. Data will be used to plan a large randomised controlled trial to assess the effects of alpha tocopherol on cardiovascular outcomes in haemodialysis patients.
Related Articles
Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing Haemodialysis: An Open-Label, Single-Centre Study
Clinical Drug Investigation, 10/15/09
Relevance Score: 87%
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 85%
Effects of thermal therapy on uremic pruritus and biochemical parameters in patients having haemodialysis
Journal of Advanced Nursing, 11/05/09
Relevance Score: 84%
Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 83%
Evaluation of Oxidant-Antioxidant Balance in Patients on Maintenance Haemodialysis: A Comparative Study of Dialyzers Membranes
Nephron: Clinical Practice, 10/12/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Zoledronic acid: an unending tale for an antiresorptive agent
Expert Opinion in Pharmacotherapy, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


